TOBRAMYCIN Side Effects

7002216-7 | Eye Discharge, Eyelid Oedema, Periorbital Oedema, Swelling Face, Vision Blurred
on Sep 17, 2010 Female patient from UNITED STATES , 58 years of age, weighting 195.0 lb, was diagnosed with chalazion and was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: eye discharge, eyelid oedema, periorbital oedema, swelling face, vision blurred. Tobramycin dosage: 1 Drop 4x Daily. During the same period patient was treated with ERYTHROMYCIN (1/2 ^ Strip Of Ointment At Bed Time) (View Erythromycin Review and Erythromycin Label ).

6979588-2 | Eyelid Ptosis, No Therapeutic Response
Patient was taking Tobramycin (View Usage). Patient had the following side effects: eyelid ptosis, no therapeutic response on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 205.5 lb, was diagnosed with chalazion and. Tobramycin dosage: 2 Drops In Right Eye 4 Times A Day.

6958628-0 | Conjunctivitis, Disease Recurrence, Feeling Abnormal, Musculoskeletal Pain, Pruritus, Rash Pruritic, Urticaria
Adverse event was reported on Aug 27, 2010 by a Female patient taking Tobramycin (View Usage) (Dosage: 2 Drops 3x 3 Times A Day Drops In Eyes) was diagnosed with conjunctivitis and. Location: UNITED STATES , 67 years of age, weighting 125.0 lb, After Tobramycin was administered, patient had the following side effects: conjunctivitis, disease recurrence, feeling abnormal, musculoskeletal pain, pruritus, rash pruritic, urticaria. During the same period patient was treated with GENTAMICIN (2 Drops 4 Times A Day Drops In Eyes) (View Gentamicin Review and Gentamicin Label ).

6924174-3 | Deafness Transitory
on Aug 12, 2010 Female patient from UNITED STATES , 27 years of age, weighting 147.3 lb, was diagnosed with pseudomonas infection and was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: deafness transitory. Tobramycin dosage: 300mg Q12h Inhal. Patient was hospitalized and became disabled.


6826008-4 | Lacrimation Increased, Photophobia, Vision Blurred, Visual Acuity Reduced, Visual Impairment
on Jul 07, 2010 Female patient from UNITED STATES , weighting 117.0 lb, was diagnosed with eyelid disorder, postoperative care and was treated with Tobramycin (View Usage). Patient had the following side effects: lacrimation increased, photophobia, vision blurred, visual acuity reduced, visual impairment. Tobramycin dosage: 1 Drop Both Eyes Twice Daily. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), FEXOFENADINE (View Fexofenadine Review and Fexofenadine Label ), ASTELIN (View Astelin Review and Astelin Label ), CRESTOR (View Crestor Review and Crestor Label ), VIVELLE DOT PATCH (View Vivelle Dot Patch Review and Vivelle Dot Patch Label ).

6711527-1 | Renal Impairment
Patient was taking Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: renal impairment on Apr 21, 2010 from IRELAND Additional patient health information: Male patient , 32 years of age, . Tobramycin dosage: 300 Mg, Bid.

6687167-X | Abdominal Pain, Erythema, Infusion Related Reaction, Nausea
Adverse event was reported on Apr 16, 2010 by a Male patient taking Tobramycin (View Usage) (Dosage: 240 Mg I.v. Daily One Dose 1700) was diagnosed with pathogen resistance, urinary tract infection pseudomonal and. Location: UNITED STATES , 26 years of age, weighting 149.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), erythema, infusion related reaction, nausea (What is nausea?). During the same period patient was treated with CARDURA (View Cardura Review and Cardura Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), CELEXA (View Celexa Review and Celexa Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

6635715-8 | Deafness, Tinnitus
on Mar 12, 2010 Female patient from UNITED STATES , 75 years of age, weighting 144.0 lb, was diagnosed with pneumonia bacterial and was treated with Tobramycin (View Usage). Patient had the following side effects: deafness, tinnitus (What is tinnitus?). Tobramycin dosage: 160mg 2xday Iv Drip. During the same period patient was treated with CEFEPIME (1gm 1xday Iv Bolus) (View Cefepime Review and Cefepime Label ).

6522207-X | Blood Creatinine Increased
on Dec 29, 2009 Female patient from UNITED STATES , 24 years of age, weighting 108.0 lb, was diagnosed with condition aggravated and was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: blood creatinine increased. Tobramycin dosage: 450 Iv Daily. During the same period patient was treated with BISACODYL (View Bisacodyl Review and Bisacodyl Label ), DOCUSATE (View Docusate Review and Docusate Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), OSELTAMIVIR (View Oseltamivir Review and Oseltamivir Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6510048-9 | Eye Irritation, Eye Pruritus, Eye Swelling, Ocular Hyperaemia
Patient was taking Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: eye irritation, eye pruritus, eye swelling, ocular hyperaemia on Jul 15, 2009 from UNITED STATES Additional patient health information: Female patient , 26 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Tobramycin dosage: . During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

6510046-5 | Eyelid Oedema, Lacrimation Increased, Ocular Hyperaemia
Adverse event was reported on Mar 05, 2009 by a Female patient taking Tobramycin (View Usage) (Dosage: ) was diagnosed with conjunctivitis infective and. Location: UNITED STATES , 53 years of age, Patient had the following side effects: eyelid oedema, lacrimation increased, ocular hyperaemia.

6425959-2 | Anaphylactic Reaction
on Nov 03, 2009 Female patient from UNITED STATES , 61 years of age, was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: anaphylactic reaction. Tobramycin dosage: .

6375185-0 | Anterior Chamber Disorder, Corneal Infection, Eye Infection Fungal, Foreign Body In Eye, Intraocular Lens Complication, Intraocular Lens Opacity, Keratitis, Photophobia, Propionibacterium Infection
on Sep 02, 2009 Male patient from UNITED STATES , 79 years of age, was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: anterior chamber disorder, corneal infection, eye infection fungal, foreign body in eye, intraocular lens complication, intraocular lens opacity, keratitis, photophobia, propionibacterium infection. Tobramycin dosage: (ophthalmic). During the same period patient was treated with VIGAMOX ((tid Ophthalmic)) (View Vigamox Review and Vigamox Label ), PREDNISOLONE ACETATE ((tid Ophthalmic)) (View Prednisolone Acetate Review and Prednisolone Acetate Label ).

6331782-X | Renal Failure Acute
Patient was taking Tobramycin (View Usage). Patient had the following side effects: renal failure acute on Aug 10, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 15 years of age, . Tobramycin dosage: 4.12 Mg/kg, 3 Day, Intravenous. Patient was hospitalized.

6298908-8 | Continuous Haemodiafiltration, Renal Failure Acute
Adverse event was reported on Jul 24, 2009 by a Female patient taking Tobramycin (View Usage) (Dosage: 3.25 Mg/kg, 3 Day, Intravenous) . Location: UNITED KINGDOM , 17 years of age, After Tobramycin was administered, patient had the following side effects: continuous haemodiafiltration, renal failure acute. During the same period patient was treated with COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

6217766-0 | Deafness Bilateral, Middle Ear Effusion
on Jun 04, 2009 Female patient from UNITED STATES , weighting 107.4 lb, was diagnosed with pneumonia (What is pneumonia?), sepsis (What is sepsis?) and was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: deafness bilateral, middle ear effusion. Tobramycin dosage: 130mg Q24h Iv. During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), ZOSYN (View Zosyn Review and Zosyn Label ), ANCEF (View Ancef Review and Ancef Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ).

6165115-9 | Balance Disorder, Inner Ear Disorder
on Apr 21, 2009 Male patient from UNITED STATES , 69 years of age, weighting 180.0 lb, was diagnosed with pseudomonas infection and was treated with Tobramycin (View Usage). Patient had the following side effects: balance disorder, inner ear disorder. Tobramycin dosage: 420 Mg/ns 100 Ml Once Daily Iv Drip.

6156993-8 | Anorexia, Dehydration, Dyspnoea, Fatigue, Headache, Myalgia, Nausea, Rebound Effect, Tinnitus
Patient was taking Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: anorexia, dehydration, dyspnoea, fatigue, headache (What is headache?), myalgia, nausea (What is nausea?), rebound effect, tinnitus (What is tinnitus?) on Apr 13, 2009 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 140.0 lb, was diagnosed with pseudomonas infection, staphylococcal infection (What is staphylococcal infection?) and. Tobramycin dosage: 100 Mg Every 8 Hours Iv. During the same period patient was treated with ZYVOX (600 Mg Every 12 Hours Po) (View Zyvox Review and Zyvox Label ), SODIUM CHLORIDE INJ (View Sodium Chloride Inj Review and Sodium Chloride Inj Label ), HEPARIN LOCK FLUSH (View Heparin Lock-flush Review and Heparin Lock-flush Label ).

6048618-7 | Bronchospasm, Dyspnoea, Wheezing
Adverse event was reported on Jan 08, 2009 by a Female patient taking Tobramycin (View Usage) (Dosage: ) . Location: AUSTRALIA , 79 years of age, Patient experienced the following unwanted or unexpected effects: bronchospasm, dyspnoea, wheezing. During the same period patient was treated with PHENYLEPHRINE HYDROCHLORIDE (View Phenylephrine Hydrochloride Review and Phenylephrine Hydrochloride Label ), PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ). Patient was hospitalized.

6038199-6 | Audiogram Abnormal, Condition Aggravated, Fear, Hypoacusis, Tinnitus
on Jan 13, 2009 Male patient from UNITED STATES , 54 years of age, weighting 215.0 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Tobramycin (View Usage). Patient had the following side effects: audiogram abnormal, condition aggravated, fear, hypoacusis, tinnitus (What is tinnitus?). Tobramycin dosage: 1 Vial In Nebulizer Two Times Daily Nasal. During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), PROZAC (View Prozac Review and Prozac Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PROTONIX (View Protonix Review and Protonix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLONASE (View Flonase Review and Flonase Label ), LYRICA (View Lyrica Review and Lyrica Label ), AMBIEN (View Ambien Review and Ambien Label ).

6004998-X | Condition Aggravated, Eye Discharge, Eye Swelling, Ocular Hyperaemia, Pathogen Resistance
on Jul 23, 2008 Female patient from UNITED STATES , child 4 years of age, was diagnosed with conjunctivitis and was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: condition aggravated, eye discharge, eye swelling, ocular hyperaemia, pathogen resistance. Tobramycin dosage: . During the same period patient was treated with OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), ERYTHROMYCIN 2% SOLUTION (View Erythromycin 2% Solution Review and Erythromycin 2% Solution Label ).

5968327-X | Toxic Epidermal Necrolysis
Patient was taking Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis on Nov 21, 2008 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with sepsis (What is sepsis?) and. Tobramycin dosage: Iv. During the same period patient was treated with DORIPENEM (Iv) (View Doripenem Review and Doripenem Label ).

5960045-7 | Abdominal Pain, Confusional State, Dyspnoea, Haemodialysis, Renal Failure Acute
Adverse event was reported on Nov 19, 2008 by a Male patient taking Tobramycin (View Usage) (Dosage: 550 Mg Iv Q 36 Hours) was diagnosed with bacteraemia and. Location: UNITED STATES , 48 years of age, weighting 242.5 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), confusional state, dyspnoea, haemodialysis, renal failure acute. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), HEPARIN (View Heparin Review and Heparin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

5892581-6 | Blood Creatinine Increased
on Sep 19, 2008 Male patient from UNITED STATES , 69 years of age, was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: blood creatinine increased. Tobramycin dosage: Iv.

5869909-6 | Cystic Fibrosis Lung, Grip Strength Decreased, Hypertonia, Hypoaesthesia, Joint Range Of Motion Decreased, Muscular Weakness, Musculoskeletal Pain, Musculoskeletal Stiffness, Neuralgic Amyotrophy
on Aug 25, 2008 Male patient from UNITED STATES , 22 years of age, was diagnosed with cystic fibrosis and was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: cystic fibrosis lung, grip strength decreased, hypertonia, hypoaesthesia, joint range of motion decreased, muscular weakness, musculoskeletal pain, musculoskeletal stiffness, neuralgic amyotrophy. Tobramycin dosage: 300 Mg, Bid. During the same period patient was treated with PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (4.5 G, Q6h) (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ), VANCOMYCIN HYDROCHLORIDE (1 G, Q8h) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), ULTRASE MT (3 Capsules With Each Meal) (View Ultrase Mt Review and Ultrase Mt Label ), ADEK (1 Df, Bid) (View Adek Review and Adek Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ). Patient was hospitalized and became disabled.

5866309-X | Azotaemia, Blood Creatinine Increased, Dysgeusia, Haemodialysis, Muscle Spasms, Nausea, Nephropathy Toxic, Oedema Peripheral, Renal Injury
Patient was taking Tobramycin (View Usage). Patient had the following side effects: azotaemia, blood creatinine increased, dysgeusia, haemodialysis, muscle spasms, nausea (What is nausea?), nephropathy toxic, oedema peripheral, renal injury on Aug 21, 2008 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with septic arthritis staphylococcal and. Tobramycin dosage: . During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE (Unk) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), INSULIN (View Insulin Review and Insulin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

5863953-0 | Neuralgic Amyotrophy
Adverse event was reported on Aug 27, 2008 by a Male patient taking Tobramycin (View Usage) (Dosage: Also Taken Inhaled 300mg Twice Daily) . Location: UNITED STATES , 22 years of age, After Tobramycin was administered, patient had the following side effects: neuralgic amyotrophy. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), COLISTIMETHATE SODIUM (View Colistimethate Sodium Review and Colistimethate Sodium Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

5862362-8 | Neuralgic Amyotrophy
on Aug 25, 2008 Male patient from UNITED STATES , 22 years of age, was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: neuralgic amyotrophy. Tobramycin dosage: Also Taken Inhaled 300mg Twice Daily. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), COLISTIMETHATE SODIUM (View Colistimethate Sodium Review and Colistimethate Sodium Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

5811134-9 | Blood Creatinine Decreased, Blood Urea Decreased, Pneumonia, Sepsis
on Jul 07, 2008 Male patient from UNITED STATES , weighting 3.91 lb, was diagnosed with infection (What is infection?) and was treated with Tobramycin (View Usage). Patient had the following side effects: blood creatinine decreased, blood urea decreased, pneumonia (What is pneumonia?), sepsis (What is sepsis?). Tobramycin dosage: 80 Mg, Bid. During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), OXACILLIN (View Oxacillin Review and Oxacillin Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

5719913-3 | Bronchopulmonary Aspergillosis, Condition Aggravated, Deafness Bilateral, Lung Infection Pseudomonal
Patient was taking Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: bronchopulmonary aspergillosis, condition aggravated, deafness bilateral, lung infection pseudomonal on Apr 21, 2008 from GERMANY Additional patient health information: Male patient , weighting 99.21 lb, was diagnosed with cystic fibrosis, aspergillosis and. Tobramycin dosage: 460 Mg/d. During the same period patient was treated with VORICONAZOLE (400 Mg, Unk) (View Voriconazole Review and Voriconazole Label ), TOBI (300 Mg, Bid) (View Tobi Review and Tobi Label ).

5684489-6 | Cough, Dyspnoea, Haemoptysis, Pneumonia, Tachypnoea
Adverse event was reported on Mar 25, 2008 by a Male patient taking Tobramycin (View Usage) (Dosage: ) was diagnosed with cystic fibrosis and. Location: BULGARIA , 16 years of age, Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, haemoptysis, pneumonia (What is pneumonia?), tachypnoea. During the same period patient was treated with CREON (View Creon Review and Creon Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ). Patient was hospitalized.

5683945-4 | Cough, Dyspnoea, Haemoptysis, Lung Disorder, Pneumonia, Tachypnoea
on Mar 19, 2008 Male patient from BULGARIA , 16 years of age, was diagnosed with cystic fibrosis and was treated with Tobramycin (View Usage). Patient had the following side effects: cough, dyspnoea, haemoptysis, lung disorder, pneumonia (What is pneumonia?), tachypnoea. Tobramycin dosage: . During the same period patient was treated with CREON (View Creon Review and Creon Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ). Patient was hospitalized.

5678756-X | Blood Creatinine Increased, Dizziness
on Mar 24, 2008 Female patient from UNITED STATES , 60 years of age, weighting 234.8 lb, was diagnosed with arthritis infective and was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: blood creatinine increased, dizziness (What is dizziness?). Tobramycin dosage: 3.6 Grams Once. During the same period patient was treated with VANCOMYCIN (3 Grams Once) (View Vancomycin Review and Vancomycin Label ).

5678707-8 | Blood Creatinine Increased
Patient was taking Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased on Mar 24, 2008 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with arthritis infective and. Tobramycin dosage: 7.2 Grams Once. During the same period patient was treated with VANCOMYCIN (6 Grams Once) (View Vancomycin Review and Vancomycin Label ).

5673211-5 | Anaphylactic Reaction
Adverse event was reported on Mar 11, 2008 by a Female patient taking Tobramycin (View Usage) (Dosage: ) was diagnosed with postoperative care and. Location: AUSTRALIA , 79 years of age, Patient had the following side effects: anaphylactic reaction. During the same period patient was treated with PHENYLEPHRINE HYDROCHLORIDE (View Phenylephrine Hydrochloride Review and Phenylephrine Hydrochloride Label ), PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ). Patient was hospitalized.

5662582-1 | Dyspnoea, Haemoptysis
on Dec 19, 2007 Male patient from UNITED STATES , 22 years of age, was diagnosed with cystic fibrosis and was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: dyspnoea, haemoptysis. Tobramycin dosage: Bid, Inhalation. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ).

5565344-9 | Eye Pain, Eyelid Oedema, Eyelid Pain
on Aug 31, 2007 Female patient from UNITED STATES , 83 years of age, was diagnosed with keratoconjunctivitis sicca and was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: eye pain, eyelid oedema, eyelid pain. Tobramycin dosage: . During the same period patient was treated with MAXIDEX (View Maxidex Review and Maxidex Label ).

5565341-3 | Eye Pain, Eye Pruritus
Patient was taking Tobramycin (View Usage). Patient had the following side effects: eye pain, eye pruritus on Nov 14, 2006 from UNITED STATES Additional patient health information: Female patient , 53 years of age, . Tobramycin dosage: .

5473420-4 | Renal Failure Acute
Adverse event was reported on Sep 21, 2007 by a Female patient taking Tobramycin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 18 years of age, After Tobramycin was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with COLOMYCIN (View Colomycin Review and Colomycin Label ). Patient was hospitalized.

5473418-6 | Renal Failure Acute
on Sep 21, 2007 Female patient from UNITED KINGDOM , 19 years of age, was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Tobramycin dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), COLOMYCIN (View Colomycin Review and Colomycin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ). Patient was hospitalized.

5473417-4 | Renal Failure Acute
on Sep 21, 2007 Female patient from UNITED KINGDOM , 52 years of age, was treated with Tobramycin (View Usage). Patient had the following side effects: renal failure acute. Tobramycin dosage: . During the same period patient was treated with COLOMYCIN (View Colomycin Review and Colomycin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

5473416-2 | Renal Failure Acute
Patient was taking Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: renal failure acute on Sep 21, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 20 years of age, . Tobramycin dosage: . During the same period patient was treated with CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), COLOMYCIN (View Colomycin Review and Colomycin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

5473415-0 | Renal Failure Acute
Adverse event was reported on Sep 21, 2007 by a Female patient taking Tobramycin (View Usage) (Dosage: ) was diagnosed with arthropathy and. Location: UNITED KINGDOM , 21 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with COLOMYCIN (View Colomycin Review and Colomycin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), ANALGESICS (View Analgesics Review and Analgesics Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

5473414-9 | Renal Failure Acute
on Sep 21, 2007 Male patient from UNITED KINGDOM , 42 years of age, was diagnosed with pleuritic pain and was treated with Tobramycin (View Usage). Patient had the following side effects: renal failure acute. Tobramycin dosage: . During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), COLOMYCIN (View Colomycin Review and Colomycin Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ).

5473411-3 | Renal Failure Acute
on Sep 21, 2007 Male patient from UNITED KINGDOM , 20 years of age, was diagnosed with musculoskeletal chest pain and was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: renal failure acute. Tobramycin dosage: . During the same period patient was treated with COLOMYCIN (View Colomycin Review and Colomycin Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

5444309-1 | Blood Creatinine Increased
Patient was taking Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased on Sep 04, 2007 from UNITED STATES Additional patient health information: Female patient , 25 years of age, . Tobramycin dosage: 120 To 320 Mg -see Text- Q12 To Q24 Hours Iv. During the same period patient was treated with ZOSYN (4.5 Grams Q6 Hours Iv) (View Zosyn Review and Zosyn Label ). Patient was hospitalized.

5440859-2 | Renal Failure Acute
Adverse event was reported on Aug 21, 2007 by a Male patient taking Tobramycin (View Usage) (Dosage: ) was diagnosed with cystic fibrosis and. Location: UNITED KINGDOM , 15 years of age, Patient had the following side effects: renal failure acute.

5440806-3 | Renal Failure Acute
on Aug 21, 2007 Female patient from UNITED KINGDOM , 15 years of age, was diagnosed with cystic fibrosis and was treated with Tobramycin (View Usage). After Tobramycin was administered, patient had the following side effects: renal failure acute. Tobramycin dosage: . During the same period patient was treated with COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).

5440805-1 | Renal Failure Acute
on Aug 21, 2007 Male patient from UNITED KINGDOM , child 9 years of age, was diagnosed with cystic fibrosis and was treated with Tobramycin (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Tobramycin dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ).

5440804-X | Haemodialysis, Renal Failure Acute
Patient was taking Tobramycin (View Usage). Patient had the following side effects: haemodialysis, renal failure acute on Aug 21, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 17 years of age, was diagnosed with cystic fibrosis and. Tobramycin dosage: . During the same period patient was treated with COLISTIN SULFATE (View Colistin Sulfate Review and Colistin Sulfate Label ).